Showing results (261-270 of 284) with videos related to
Sort By:
Pageof 29
Annals of Surgical Oncology|February 12, 2013
The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinomaDaniel E Abbott, Ching-Wei David Tzeng, Ryan P Merkow, et al.Plos One|May 4, 2010
Isoform-specific upregulation of palladin in human and murine pancreas tumorsSilvia M Goicoechea, Brian Bednarski, Christianna Stack, et al.Journal of Surgical Oncology|May 1, 2023
Evaluation of emergency department treat-and-release encounters after major gastrointestinal surgeryBrian C Brajcich, Julie K Johnson, Jane L Holl, et al.Surgery|October 1, 2013
Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumorsJovenel Cherenfant, Susan J Stocker, Mistry K Gage, et al.Cardiovascular and Interventional Radiology|June 22, 2022
Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient CohortAakash N Gupta, Andrew C Gordon, Ahmed Gabr, et al.Surgery|December 3, 2014
Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumorsJovenel Cherenfant, Mark S Talamonti, Curtis R Hall, et al.Plos Medicine|July 21, 2010
A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinomaJeran K Stratford, David J Bentrem, Judy M Anderson, et al.Nature Genetics|September 8, 2015
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinomaRichard A Moffitt, Raoud Marayati, Elizabeth L Flate, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 20, 2014
Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional studyJeffrey M Sutton, David A Kooby, Gregory C Wilson, et al.Science Translational Medicine|December 18, 2012
Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancerNichole R Blatner, Mary F Mulcahy, Kristen L Dennis, et al.Pageof 29